Skip to main content
. 2009 Sep 16;8:48. doi: 10.1186/1475-2859-8-48

Table 1.

Plasmids and oligonucleotide primers used in this study

Plasmids or primers Phenotypes or sequencesa Source or reference
Plasmids
 pHT304 AmprEmr, E. coli-B. thuringiensis shuttle cloning vector, 6528 bp [39]
 pGFPuv Ampr, plasmid vector carrying a variant of gfp, 3336 bp CLONTECH Lab, Inc.
 pBMB3305 AmprEmr, pHT304 derivative harbouring insecticidal gene cry3Aa with promoter Pcry3Aa, ~12.6 kb Laboratory collection
 pMB172 Ampr, pTYB12 derivative harbouring wlacD, 8867 bp [20]
 pMB160 AmprEmr, pHT304 derivative harbouring mba-gfp fusion gene, 8194 bp This study
 pMB161 AmprEmr, pHT304 derivative harbouring mbp-gfp fusion gene, 8667 bp This study
 pMB162 AmprEmr, pHT304 derivative harbouring mbg-gfp fusion gene, 8648 bp This study
 pMB163 AmprEmr, pHT304 derivative harbouring promoter Pcry3Aa, mbg and gfp, 9365 bp This study
 pMB164 AmprEmr, pHT304 derivative harbouring Pcry3Aa, mbgn and gfp, 8466 bp This study
 pMB165 AmprErmr, pHT304 derivative harbouring Pcry3Aa, mbgc and gfp, 9002 bp This study
 pMB166 AmprEmr, pHT304 derivative harbouring Pcry3Aa, lysM1 and gfp, 8276 bp This study
 pMB167 AmprEmr, pHT304 derivative harbouring Pcry3Aa, lysM2 and gfp, 8294 bp This study
 pMB168 AmprEmr, pHT304 derivative harbouring Pcry3Aa, (mbgn)2 and gfp, 8777 bp This study
 pMB169 AmprEmr, pHT304 derivative harbouring Pcry3Aa, (mbgn)3 and gfp, 9098 bp This study
 pMB173 AmprEmr, pHT304 derivative harbouring Pcry3Aa and wlacD, 8879 bp This study
 pMB174 AmprEmr, pHT304 derivative harbouring Pcry3Aa, (mbgn) 2 and wlacD, 9521 bp This study
Oligonucleotide primersb
 BT101 5'-CGAGAATTCTGACAAGTGCGACACGTT-3'
 BT102 5'-TTCTTCTCCTTTACTCATACAGAAAATATGTTTACCG-3'
 BT103 5'-CGGTAAACATATTTTCTGTATGAGTAAAGGAGAAGAA-3'
 BT301 5'-CGTGAATTCCACTGTCAGTATAACACC-3'
 BT302 5'-TTCTTCTCCTTTACTCATCCTAACTAAATATGGCAG-3'
 BT303 5'-CTGCCATATTTAGTTAGGATGAGTAAAGGAGAAGAA-3'
 P1 5'-TTACCCGGGCTTCCCTTCTTTCACTTC-3'
 P2 5'-TTCTTCTCCTTTACTCATGCCCTTTTTCGTAATCGT-3'
 P3 5'-ACGATTACGAAAAAGGGCATGAGTAAAGGAGAAGAA-3'
 P4 5'-AAACTGCAGTTATTTGTAGAGCTCATCCATGC-3'
 P5 5'-ACGGGAATTCGGATTCAAAATAGCCCTG-3'
 P6 5'-CTGTCTAGACGGATTCATTTTTCTTCC-3'
 P7 5'-CCAAGTTCTAGAATGATTCAAATTGTAACGG-3'
 P8 5'-GCTAGATCTGCCCTTTTTCGTAATCGT-3'
 P9 5'-ACGAGATCTATGAGTAAAGGAGAAGAA-3'
 P10 5'-TCTAGAGATCTGATGGATTCTACAGCTCG-3'
 P11 5'-CTGTCTAGAGTTAATGCTACACGTGCC-3'
 P12 5'-GCAAGATCTAACGATAAGTGCCTGACC-3'
 P13 5'-CGCTCTAGATATGTACAGCCTGGTGAC-3'
 P14 5'-CGCGGATCCATGATTCAAATTGTAACGG-3'
 P15 5'-CTGTCTAGA ATGCAACGTCGTGATTTC-3'
 P16 5'-AAACTGCAGTTATACCGTAAACCCTAAC-3'
 P17 5'-GCAAGATCTATGCAACGTCGTGATTTC-3'

a Emr, erythromycin resistance; Ampr, ampicillin resistance; cry3Aa, B. thuringiensis insecticidal gene;Pcry3Aa, the promoter of cry3Aa; gfp, green fluorescent protein gene; wlacD, a mutated S. dysenteriae laccase gene [20]; mbg, a putative N-acetylglucosaminidase gene from B. thuringiensis YBT-1520; mbgn, N-terminal domain of mbg; mbgc, C-terminal domain of mbg; (mbgn)2, two tandemly aligned repeats of N-terminal domain of mbg.

b The underlined sequences indicates the restriction enzyme sites.